Menu

Michael Gilman, PhD

  • Founder and Chief Executive Officer of Padlock Therapeutics & Venture Partner at Atlas Venture
  • Former Executive Vice President of Research, Biogen Idec
  • Growing companies from inception to licensed products and M&As; immuno-inflammatory diseases, cancer and neurology